1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
657B3BB1F6F01BFD00025877500290DFF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/trends-in-digital-biopharma-launches?opendocument
18
19opendocument
203.89.204.127
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25Main






Trends in Digital Biopharma Launches

CHAPEL HILL, N.C., Feb. 23, 2021/PRNewswire/ -- Over the past year, companies have implemented new initiatives and technologies to further progress their digital launch transformation. Digital approaches can be leveraged to help build effective launch strategies, but how is this shift to digital affecting different parts of the organization?

“Digital Trends in Biopharma Launch Strategy and Investment” is a 36-page new report from Best Practices, LLC that probes key topics including:

Digital Activities and Acceleration Digital Impact on a Successful Launch Investment Trend & Effective Assessment

According to our research, highest impact digital launch activities and approaches include:

1. Segmentation / Digital Channel Preference (45% of organizations cited a very high positive impact)
2. Digital Analytics, Insights, and Forecasting (36% of organizations cited a very high positive impact)

For more data regarding digital launch trends, download the complimentary summary at https://www.best-in-class.com/rw95.htm.



ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.